Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Janssen - Cilag International

02 3Janssen-Cilag Ag

03 3Janssen-Cilag International N.V.

04 3Janssen-Cilag International NV

05 6Janssen-Cilag International Nv

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 22/08/2024

Application Number : 20230909000014

Regulatory Info : Approved

Registration Country : Sweden

blank

02

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 22/08/2024

Application Number : 20230909000021

Regulatory Info : Approved

Registration Country : Sweden

blank

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 22/08/2024

Application Number : 20230909000038

Regulatory Info : Approved

Registration Country : Sweden

blank

04

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 14/01/2025

Application Number : 67660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

09

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Erdafitinib

Brand Name : Balversa

Dosage Form : Film-Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank